Last reviewed · How we verify
NCT06353776
MicroPulse Transscleral Laser Therapy and Its Short-term Impact on Ocular Surface
NA trial testing conjunctival biopsy after micropulse transscleral laser therapy in Conjunctiva in 15 participants. Completed in 31 October 2023.
31 October 2023
Quick facts
| Lead sponsor | University Tunis El Manar |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 3 May 2023 |
| Primary completion | 31 October 2023 |
| Estimated completion | 31 October 2023 |
| Sites | 1 location across Tunisia |
Drugs / interventions tested
- conjunctival biopsy after micropulse transscleral laser therapy
Conditions studied
- Conjunctiva — all drugs for Conjunctiva →
- Cornea — all drugs for Cornea →
Sponsor
University Tunis El Manar
Who can join
18 and older, any sex, with Conjunctiva or Cornea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
MicroPulse transscleral laser therapy (TLT) is proven to be effective in reducing intraocular pressure with minimal complications in either primary or secondary glaucoma. However, its impact on the human ocular surface remains unexplored. This study aims to bridge this gap by examining the clinical and histopathological effects of MicroPulse TLT on the ocular surface.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06353776
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Tunis El Manar trials
Trials by the same sponsor.
- NCT07467967 — Impact of Date Consumption on Metabolic Control and Oxidative Stress in Patients With Type 2 Diabetes · NA · not yet recruiting
- NCT07378904 — Sterile Water Injection vs Morphine for Renal Colic · NA · active not recruiting
- NCT07313553 — Prevention of Rebound Pain After Axillary Block · NA · not yet recruiting
- NCT07240961 — Lumbal Erector Spinae Plane Block for Pain Management After Total Hip Arthroplasty · NA · recruiting
- NCT07194967 — Virtual Reality for Pain and Anxiety Relief in Labor · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06353776 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Tunis El Manar
- Last refreshed: 9 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06353776.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing